In the world of medical device regulation, few names carry the weight and respect of Alan Schwartz. As the President and Founder of mdi Consultants, Schwartz has spent decades helping companies navigate the often-complex landscape of FDA and global regulatory compliance.
What sets him apart is not just his deep technical expertise, but his unique perspective shaped by years of direct experience within the FDA itself. This insider knowledge, combined with a lifelong commitment to client success and innovation, has allowed mdi Consultants to become a trusted partner for hundreds of companies worldwide.
From Biology Graduate to FDA Insider
Alan Schwartz’s career began in an era when the job market for new graduates was far from forgiving. In 1972, he completed his degree in biology during a recession that left few options for someone with ambitions beyond the ordinary. “Two jobs were available at the time,” Schwartz recalls, “one was sorting reptiles at the Museum of Natural History, and the other was with the FDA. I decided to work with people rather than dead lizards and snakes.”
At the time, the FDA was relatively unknown to the public, and Schwartz had never imagined a career in government. Yet within days of starting, he recognized the critical role the Agency played in protecting public health and the potential for a career that could combine scientific knowledge with regulatory oversight.
Over the next six years, Schwartz rose from entry-level investigator to supervisor of field operations, managing a team of 13 investigators. He even served as acting director of the New York District investigations branch—a role that gave him firsthand insight into both the agency’s operations and the challenges companies face in compliance.
Founding mdi Consultants: A Vision Realized
Schwartz’s time at the FDA provided more than just experience; it sparked a vision. He saw that small companies often lacked the internal regulatory expertise necessary to navigate the complexities of FDA rules. Many businesses struggled to understand the expectations of the agency, particularly when new regulations emerged.
Recognizing an opportunity, Schwartz made a bold move: he resigned from a high-level government position to launch mdi Consultants, a firm dedicated to helping companies understand and meet FDA expectations while maintaining operational success.
The timing was ideal. Congress had recently introduced a new set of regulations specifically for the medical device industry. Few, if any, consultants specialized in this area, leaving small and mid-sized companies without guidance. Schwartz’s understanding of the FDA’s internal workings, combined with his affinity for helping small businesses, positioned mdi Consultants to fill this critical gap.
Innovating Client-Centered Consulting
From the outset, Schwartz wanted mdi to operate differently from traditional consulting firms. He observed that many of the company’s potential clients were accustomed to lawyers billing by the hour—a system that often discouraged them from seeking advice when they needed it most. “Clients were afraid to call for help because they didn’t want to incur charges every time they picked up the phone,” Schwartz explains.
To solve this, mdi introduced flat-fee projects and monthly retainers, allowing clients to access regulatory expertise without the fear of escalating costs. This approach was revolutionary in the 1970s and remains a hallmark of the firm today.
By providing clear, predictable pricing, mdi consultants enabled companies to engage fully in problem-solving and strategic planning without financial hesitation. Many clients have maintained long-term relationships with mdi, some for over three decades, relying on the firm for regulatory strategies, FDA submissions, internal audits, due diligence, and even expert witness services.
Regulatory Insight: Learning from the FDA
Schwartz’s early experience at the FDA profoundly shaped mdi’s approach to regulatory problem-solving. He emphasizes that the FDA, like many government agencies, is reactionary rather than proactive, often responding to Congress’ directives rather than initiating change. “Understanding the agency’s motivations is critical,” he says. “It’s about learning how they evaluate companies, where they can negotiate, and how they decide to enforce compliance.”
This perspective allows Schwartz and his team to guide clients through complex regulatory challenges strategically. Rather than viewing compliance as a series of hurdles, mdi helps companies anticipate regulatory expectations, build trust with the FDA, and address issues before they become crises. The result is a proactive, confident approach to compliance that safeguards both operations and reputation.
Global Reach and Harmonized Quality
Over the years, mdi Consultants expanded beyond the U.S., offering regulatory guidance across international markets. Schwartz notes that while regulations may differ, the principles of quality are universal. “Quality is consistent worldwide,” he says. “The FDA QSR and ISO13485 standards are now converging, which allows companies to implement a harmonized system globally.”
By consulting with hundreds of companies internationally, Schwartz has gained a unique perspective on organizational management and quality culture. Many regulatory challenges, he observes, stem not from technical failures but from a lack of top-down commitment to quality. mdi helps leadership teams understand these systemic issues and implement sustainable solutions that ensure compliance while fostering operational excellence.
Education as a Tool for Innovation
Education and knowledge-sharing have always been central to Schwartz’s philosophy. His expertise combines formal training with extensive real-world experience—investigating violations, supervising teams, and navigating complex regulatory scenarios. “There’s no substitute for learning in the field,” he explains. mdi Consultants emphasizes training and ongoing education for both clients and employees, ensuring that teams remain informed, capable, and innovative in their approach to regulatory challenges.
Navigating Regulatory Uncertainty
Regulatory uncertainty is a common concern for companies, particularly start-ups. Schwartz argues that uncertainty is often avoidable with the right approach. “A good business leader understands regulatory risks, pathways, costs, and timelines before committing to any venture,” he says. mdi Consultants provides clients with clear guidance, mapping out regulatory responsibilities and potential challenges. By doing so, companies can innovate confidently, remain competitive, and avoid costly missteps.
Whether it’s creating a regulatory strategy, conducting internal audits, preparing submissions for FDA approval, or offering expert testimony, Schwartz ensures that mdi clients are prepared for every scenario. The firm’s structured approach transforms regulatory compliance from a potential obstacle into a strategic advantage.
A Legacy of Client Success
Alan Schwartz’s career is a testament to the power of experience-driven insight, innovation, and client-focused strategy. By combining an insider’s understanding of the FDA with a commitment to accessibility and practical solutions, he has built mdi Consultants into a global leader in regulatory consulting. Today, companies rely on mdi not just for compliance, but for guidance that enables growth, mitigates risk, and enhances operational efficiency.
Schwartz’s philosophy is simple yet powerful: regulatory expertise should empower businesses, not intimidate them. Through decades of service, mdi Consultants has demonstrated that understanding regulations, anticipating challenges, and maintaining quality standards worldwide is not only achievable but a key driver of business success.
With Alan Schwartz at the helm, mdi Consultants continues to set the standard for excellence, innovation, and trust in the world of regulatory consulting.